BUY The South Indian Bank Limited — Deven Mehata, IDBI Capital Markets and Securities
byDeven Mehata, IDBI Capital Markets and SecuritiesHorizon: 1–3 months25 Sept 2026via NDTV Profit
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·9 Nov · yesterday
1 advisor has an active long-term BUY call on this stock
Advisor consensus · adjacent horizon·21 Oct · 3w ago
South Indian Bank reported its highest-ever quarterly net profit of Rs 426.13 crore for Q2 FY 2026-27, a 21.28% increase year-on-year, alongside growth in net interest income and improved asset qualit
BSE · Company Update·15 Oct · 4w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on The South Indian Bank
- BUY — Mahesh Ojha, Kantilal Chhaganlal Securities9 Nov 2026 · ~3 months · target ₹65 · Active
- BUY — Sumeet Bagadia, Choice Broking8 Nov 2026 · ~3 months · target ₹63.5 · Active
- BUY — Kush Bohra28 Oct 2026 · ~2 weeks · target ₹56.5 · Target hit
- BUY — Pradeep Haldar, PHD Capital23 Oct 2026 · ~2 weeks · target ₹64 · Expired
- BUY — BOB Capital Markets21 Oct 2026 · ~1 year · target ₹66 · Active
More from Deven Mehata, IDBI Capital Markets and Securities
- BUY Balmer Lawrie & Company11 Nov 2026 · ~2 weeks · target ₹200 · Active
- BUY Waaree Energies11 Nov 2026 · ~2 weeks · target ₹2,750 · Active
- BUY Central Depository Services (India)9 Nov 2026 · ~2 weeks · target ₹1,420 · Target hit
- BUY Alkem Laboratories9 Nov 2026 · ~2 weeks · target ₹5,730 · Active
- BUY Onesource Specialty Pharma9 Nov 2026 · ~2 weeks · target ₹1,765 · Active

